Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Quaratusugene Ozeplasmid |
Synonyms | |
Therapy Description |
Quaratusugene Ozeplasmid is a complex of liposomal nanoparticles with a plasmid expression cassette encoding the human FUS1 protein, which may lead to induction of tumor cell apoptosis and suppression of tumor cell proliferation (PMID: 15486560). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Quaratusugene Ozeplasmid | GPX-001|DOTAP:cholesterol-Fus1 liposome complex|INGN 401|DOTAP:chol-Fus1 | Quaratusugene Ozeplasmid is a complex of liposomal nanoparticles with a plasmid expression cassette encoding the human FUS1 protein, which may lead to induction of tumor cell apoptosis and suppression of tumor cell proliferation (PMID: 15486560). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01455389 | Phase Ib/II | Quaratusugene Ozeplasmid Erlotinib Diphenhydramine Dexamethasone | FUS1-nanoparticles and Erlotinib in Stage IV Lung Cancer | Terminated | USA | 0 |